Restless Legs Syndrome

• FDA approval · 2010-10-08
  FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Original Application (Torrent Pharmaceuticals Limited)

  FDA approved an original application for pramipexole dihydrochloride from Torrent Pharmaceuticals Limited, a generic version of the anti-Par…

• FDA approval · 2010-10-08
  FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Original Application (Glenmark Pharmaceuticals Inc., USA)

  The FDA approved Glenmark's original application for pramipexole dihydrochloride tablets (generic) for indications corresponding to the refe…

• FDA approval · 2010-03-24
  FDA Approved: ROPINIROLE — Original Application (Alembic Pharmaceuticals Limited)

  FDA approves Alembic Pharmaceuticals Limited's original ANDA for ropinirole, a generic version of a dopamine agonist used to treat Parkinson…

• FDA approval · 2010-02-25
  FDA Approved: ROPINIROLE — Original Application (Glenmark Pharmaceuticals Inc., USA)

  FDA approved Glenmark's original ANDA for ropinirole, enabling a generic version of the drug. Ropinirole is used to treat Parkinson's diseas…

• FDA approval · 2008-05-05
  FDA Approved: ROPINIROLE HYDROCHLORIDE — Original Application (SOLCO HEALTHCARE US, LLC)

  FDA approves Solco Healthcare US, LLC's original application for ropinirole hydrochloride tablets (generic). The approval covers use for Par…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2007-05-09
  FDA Approved: NEUPRO — Original Application (UCB, Inc.)

  FDA approved NEUPRO (rotigotine) transdermal patch from UCB, Inc. under NDA021829 for the treatment of Parkinson's disease and restless legs…